Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis
Authors
Nicole Isbel
Larry A. Greenbaum (ORCID: https://orcid.org/0000-0002-2490-021X)
Anja Gaeckler
Johan Vande Walle (ORCID: https://orcid.org/0000-0001-9700-5358)
Hans Dieperink (ORCID: https://orcid.org/0009-0003-0726-835X)
Newcastle upon Tyne Hospitals NHS Foundation Trust
Odense Universitetshospital
University College London Hospitals NHS Foundation Trust
Universitätsklinikum Heidelberg
Universitätsklinikum Tübingen
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis
Nicole Isbel, Larry A. Greenbaum, Anja Gaeckler, Johan Vande Walle et al.
Journal
Clinical Transplantation
Topics
Complement system in diseases
article
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis
Nicole Isbel, Larry A. Greenbaum, Anja Gaeckler, Johan Vande Walle, Hans Dieperink, Imad Al‐Dakkak, Nuria Saval, Margriet Eygenraam
article en
Abstract
No abstract available for this paper.
Publication Tag
Clinical TransplantationVol. 39(9)
Institutions
Emory University (US), Ghent University Hospital (BE), Brampton Civic Hospital (CA), Odense University Hospital (DK), Princess Alexandra Hospital (AU), Essen University Hospital (DE), Children's Healthcare of Atlanta (US), AstraZeneca (United States) (US), Alexion Pharma (Switzerland) (CH), University of Duisburg-Essen (DE)
Funders
AstraZeneca, Alexion Pharmaceuticals, Georgetown University, Universitätsklinikum Essen, University College London, Newcastle upon Tyne Hospitals NHS Foundation Trust, Odense Universitetshospital, University College London Hospitals NHS Foundation Trust, Universitätsklinikum Heidelberg, Universitätsklinikum Tübingen
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry Analysis — Nicole Isbel, Larry A. Greenbaum, et al. · Clinical Transplantation (2025) | TGRS Research Map | TGRS